Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.
1 other identifier
observational
10
1 country
1
Brief Summary
Vicryl (polyglactin) 10-0 resorbable suture is rarely used, little known to ophthalmologists but may offer therapeutic and practical advantages in eligible cases of corneal trauma, particularly during a COVID-19 pandemic. This has imposed new sanitary restrictions : limited access to the operating room in ophthalmology only for functional emergencies and a drastically reduced capacity for external consultations in favor of teleconsultation. The aim of this study is to evaluate the Vicryl 10-0 (polyglactin 910) resorbable monofilament suture in corneal trauma, rather than classic Nylon 10-0: structural and functional results, and adaptation of postoperative follow-up during a sanitary crisis period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2020
CompletedFirst Submitted
Initial submission to the registry
February 1, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2021
CompletedMarch 29, 2022
January 1, 2022
9 months
February 1, 2021
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change visual acuity (Snellen scale) from baseline and 2, 6, 12 and 18 months after the intervention
Collected in the medical record.
Months: 0, 2, 6, 12, 18
change Visual acuity (Parinaud scale) from baseline and 2, 6, 12 and 18 months after the intervention
Collected in the medical record.
Months: 0, 2, 6, 12, 18
Secondary Outcomes (3)
Astigmatism (diopter)
Months: 0, 2, 6, 12, 18
Number of postoperative external consultations
Months: 0, 2, 6, 12, 18
Adverse events
Months: 0, 2, 6, 12, 18
Study Arms (1)
corneal trauma sutured with Vicryl 10-0 monofilament
corneal trauma sutured with Vicryl 10-0 monofilament will be included. They will have data collection of medical records.
Interventions
Collection of clinical and paraclinical data during preoperative consultation Collection of clinical and paraclinical data during post-operative consultations Tele-consultation to determine if criteria for good healing / adherence, treatment tolerance / response to questions Remote follow-up 6 and 12 months after the trauma
Eligibility Criteria
Patients who had an emergency eye surgery in the Saint-Etienne University Hospital from 18/03/2020 to 05/12/2020
You may qualify if:
- Corneal penetrating injury and/or lamellar laceration
You may not qualify if:
- Corneal Penetrating injury trauma requiring necessarily ONLY Nylon 10-0
- Traumatism requiring necessarily a cryopreserved human amniotic membrane (for example)
- Traumatism eligible for biological glue (long-axis wound \< 2 mm)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Saint-Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thibaut GARCIN, MD PhD
CHU de Saint-Etienne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2021
First Posted
February 2, 2021
Study Start
March 18, 2020
Primary Completion
December 5, 2020
Study Completion
December 5, 2021
Last Updated
March 29, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share